Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Invivyd Inc (IVVD)

Invivyd Inc (IVVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Invivyd Inc 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 USA

https://invivyd.com P: 781-819-0080

Description:

INVIVYD INC. is a biopharmaceutical company. It involved in developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. INVIVYD INC., formerly known as Adagio Therapeutics, is based in WALTHAM, Mass.

Key Statistics

Overview:

Market Capitalization, $K 289,938
Enterprise Value, $K 89,298
Shares Outstanding, K 119,316
Annual Sales, $ 0 K
Annual Net Income, $ -198,640 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -43,500 K
EBIT, $ -219,780 K
EBITDA, $ -218,870 K
60-Month Beta 0.89
% of Insider Shareholders 17.90%
% of Institutional Shareholders 70.36%
Float, K 97,958
% Float 82.10%
Short Volume Ratio 0.46

Growth:

1-Year Return 68.75%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.38 on 05/09/24
Latest Earnings Date N/A
Earnings Per Share ttm -1.87
EPS Growth vs. Prev Qtr 43.28%
EPS Growth vs. Prev Year -18.75%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IVVD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -93.58%
Return-on-Assets % -79.93%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.50
Book Value/Share 1.50
Interest Coverage -3.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar